Wnt/beta-catenin Signaling Promotes Expansion of Isl-1-positive Cardiac Progenitor Cells Through Regulation of FGF Signaling
Overview
Authors
Affiliations
The anterior heart field (AHF), which contributes to the outflow tract and right ventricle of the heart, is defined in part by expression of the LIM homeobox transcription factor Isl-1. The importance of Isl-1-positive cells in cardiac development and homeostasis is underscored by the finding that these cells are required for cardiac development and act as cardiac stem/progenitor cells within the postnatal heart. However, the molecular pathways regulating these cells' expansion and differentiation are poorly understood. We show that Isl-1-positive AHF progenitor cells in mice were responsive to Wnt/beta-catenin signaling, and these responsive cells contributed to the outflow tract and right ventricle of the heart. Loss of Wnt/beta-catenin signaling in the AHF caused defective outflow tract and right ventricular development with a decrease in Isl-1-positive progenitors and loss of FGF signaling. Conversely, Wnt gain of function in these cells led to expansion of Isl-1-positive progenitors with a concomitant increase in FGF signaling through activation of a specific set of FGF ligands including FGF3, FGF10, FGF16, and FGF20. These data reveal what we believe to be a novel Wnt-FGF signaling axis required for expansion of Isl-1-positive AHF progenitors and suggest future therapies to increase the number and function of these cells for cardiac regeneration.
Emerging Insights into Sall4's Role in Cardiac Regenerative Medicine.
Yang J Cells. 2025; 14(3).
PMID: 39936946 PMC: 11817359. DOI: 10.3390/cells14030154.
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance.
Edirisinghe O, Ternier G, Alraawi Z, Kumar T Biomolecules. 2025; 14(12.
PMID: 39766329 PMC: 11726770. DOI: 10.3390/biom14121622.
The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, Jing X, Yan Y Signal Transduct Target Ther. 2024; 9(1):368.
PMID: 39715759 PMC: 11666744. DOI: 10.1038/s41392-024-02069-8.
Pharmacologically inducing regenerative cardiac cells by small molecule drugs.
Zhou W, He K, Wang C, Wang P, Wang D, Wang B Elife. 2024; 13.
PMID: 39651957 PMC: 11627505. DOI: 10.7554/eLife.93405.
A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation.
Padmanabhan A, de Soysa T, Pelonero A, Sapp V, Shah P, Wang Q Nat Cardiovasc Res. 2024; 3(3):317-331.
PMID: 39196112 PMC: 11361716. DOI: 10.1038/s44161-024-00431-1.